Tine A. Bækdal

Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist

Stephen T. Buckley, Tine A. Bækdal, Andreas Vegge et al. · Science Translational Medicine · 2018 · 513 citations

Pharmacy, Pharmacology, Physiology +17

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes

Charlotte Granhall, Morten Donsmark, Thalia Marie Blicher et al. · Clinical Pharmacokinetics · 2018 · 179 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Liraglutide suppresses postprandial triglyceride and apolipoprotein <scp>B48</scp> elevations after a fat‐rich meal in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, cross‐over trial

Kjeld Hermansen, Tine A. Bækdal, Maria Düring et al. · Diabetes Obesity and Metabolism · 2013 · 142 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes

Catherine Gibbons, John E. Blundell, Søren T. Hoff et al. · Diabetes Obesity and Metabolism · 2020 · 132 citations · Full text

Agriculture, Pharmacology, Pharmacotherapy +17

Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials

Rune Viig Overgaard, Andrea Navarria, Steen H. Ingwersen et al. · Clinical Pharmacokinetics · 2021 · 114 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17